Use of Cilostazol, a Novel Antiplatelet Agent, in a Post-Palmaz-Schatz Stenting Regimen

This publication has 14 references indexed in Scilit:

• A Randomized Comparison of Antiplatelet and Anticoagulant Therapy after the Placement of Coronary-Artery Stents
  New England Journal of Medicine, 1996
• Is ticlopidine a necessary component of antiplatelet regimens following coronary artery stenting
  Journal of the American College of Cardiology, 1996
• Intracoronary stenting without coumadin: One month results of a French multicenter study
  Catheterization and Cardiovascular Diagnosis, 1995
• Intracoronary Stenting Without Anticoagulation Accomplished With Intravascular Ultrasound Guidance
  Circulation, 1995
• A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease
  New England Journal of Medicine, 1994
• A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease
  New England Journal of Medicine, 1994
• Cilostazol
  Cardiovascular Drug Reviews, 1993
• A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
  New England Journal of Medicine, 1989
• Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
  Circulation, 1988
• Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. IV. Synthesis and biological activity of the metabolites of 6-(4-(1-cyclohexyl-1H-5-tetrazolyl)butoxy)-2-oxo-1,2,3,4-tetrahydroquinoline(OPC-13013).
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1985